These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN. JELJASZEWICZ J; NIEWIAROWSKI S; POPLAWSKI A; PROKOPOWICZ J; WOROWSKI K Thromb Diath Haemorrh; 1965 Jun; 13():457-69. PubMed ID: 14347867 [No Abstract] [Full Text] [Related]
6. VARIABILITY OF THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN. TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC Am J Physiol; 1965 Mar; 208():521-7. PubMed ID: 14264744 [No Abstract] [Full Text] [Related]
7. THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY. MONKHOUSE FC Thromb Diath Haemorrh; 1963 Jul; 143():387-94. PubMed ID: 14081261 [No Abstract] [Full Text] [Related]
8. THE ACTION OF A PROTEOLYTIC ENZYME FROM ASPERGILLUS ORYZAE ON COMPONENTS OF THE BLOOD CLOTTING SYSTEM. MONKHOUSE FC; DARAMOLA F; GILLESPIE RJ Can J Physiol Pharmacol; 1964 Jul; 42():377-84. PubMed ID: 14324171 [No Abstract] [Full Text] [Related]
10. ISOLATION AND PROPERTIES OF ANTICOAGULANTS FROM FIBRINOLYSED AND HUMAN HEART-PUMP PLASMAS. TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E Can J Physiol Pharmacol; 1964 Mar; 42():169-87. PubMed ID: 14329312 [No Abstract] [Full Text] [Related]
11. [THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM]. SCHIMPF K; CIBELIUS A; MARDINI R Klin Wochenschr; 1964 Jul; 42():637-40. PubMed ID: 14248608 [No Abstract] [Full Text] [Related]
12. ANTITHROMBIN ACTIVITY (HEPARIN CO-FACTOR) IN PLASMA AFTER MAJOR SURGERY IN HEPARINIZED PATIENTS. OLSSON P; VON FRANCKEN ; NORDSTROEM S Acta Chir Scand; 1964 Jun; 127():578-83. PubMed ID: 14175132 [No Abstract] [Full Text] [Related]
13. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate. Andersen P; Godal HC Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046 [TBL] [Abstract][Full Text] [Related]
14. [The antithrombin effect of the fibrinogen of some mammals]. BURSTEIN M; GUINAND A Sang; 1954; 25(9):919-24. PubMed ID: 13225578 [No Abstract] [Full Text] [Related]
16. Studies on an antithrombin. III. A plasma antithrombin test for the prediction of intravascular clotting. KAY JH; HUTTON SB; WEISS GN; OCHSNER A Surgery; 1950 Jul; 28(1):24-8. PubMed ID: 15442785 [No Abstract] [Full Text] [Related]
17. Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor. Yin ET; Wessler S; Stoll PJ J Biol Chem; 1971 Jun; 246(11):3712-9. PubMed ID: 4102937 [No Abstract] [Full Text] [Related]
18. [DIFFERENTIATION OF THE INHIBITORS OF THE CONVERSION OF FIBRINOGEN INTO FIBRIN]. VERMYLEN C; VERSTRAETE M Nouv Rev Fr Hematol; 1965; 5():376-82. PubMed ID: 14307711 [No Abstract] [Full Text] [Related]
19. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of the thrombin/antithrombin III reaction from amidolytic activity of the enzyme at high salt concentration. Oshima G Thromb Res; 1989 May; 54(3):225-35. PubMed ID: 2749614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]